Eli Lilly pulls PBS application for eczema drug

4 minute read


The pharma company claims that terms set by the Australian government meant it was ‘commercially unviable’ to proceed with a PBS listing.


This content is for members only.
Join Now

End of content

No more pages to load

Log In Register ×